TNFSF13B and myeloid sarcoma: Our results are partially in contrast to this observation, but are in line with a other report where stable MS patients without relapses exhibited significantly higher BAFF levels than relapsing patients and treatment with interferon-β and immunosuppressants raised BAFF blood levels11.